PACE-CME

Episodes 1-15 of 15

• 

  RestartResume

  IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies

  CME/CE

  IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies

  • 

    

    Jörg Latus, MD

    Peer

  • 

    

    Jürgen Floege, MD

    Peer

  0.25 credits

• 

  RestartResume

  Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs

  CME/CE

  Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs

  • 

    

    Faiez Zannad, MD, PhD

    Peer

  • 

    

    John McMurray, MD

    Peer

  0.25 credits

• 

  RestartResume

  The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care

  CME/CE

  The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care

  • 

    

    Pablo Garcia-Pavia, MD, PhD

    Peer

  • 

    

    Francesco Cappelli, MD

    Peer

  0.50 credits

• 

  RestartResume

  ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection

  MinuteCE®

  ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection

  • 

    

    Csaba P. Kovesdy, MD

    Peer

  • 

    

    Finnian R. McCausland, MD

    Peer

  1.25 program credits

• 

  RestartResume

  ns-MRAs and eGFR Slope: The Kidney Perspective

  MinuteCE®

  ns-MRAs and eGFR Slope: The Kidney Perspective

  • 

    

    Csaba P. Kovesdy, MD

    Peer

  • 

    

    Finnian R. McCausland, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Optimizing HF Outcomes Across the Spectrum: Emerging Evidence

  MinuteCE®

  Optimizing HF Outcomes Across the Spectrum: Emerging Evidence

  • 

    

    Akshay S. Desai, MD

    Peer

  • 

    

    John McMurray, MD

    Peer

  1.25 program credits
• advertisement

• 

  RestartResume

  Mastering MRA Monitoring: The Key to Success

  MinuteCE®

  Mastering MRA Monitoring: The Key to Success

  • 

    

    Akshay S. Desai, MD

    Peer

  • 

    

    John McMurray, MD

    Peer

  1.25 program credits

• 

  MinuteCE®

  Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care

  • 

    

    Pardeep Jhund, MD, PhD

    Peer

  • 

    

    Hiddo L. Heerspink, PhD

    Peer

  • 

    

    John McMurray, MD

    Peer

  • 

    

    Akshay S. Desai, MD

    Peer

  • 

    

    Csaba P. Kovesdy, MD

    Peer

  • 

    

    Finnian R. McCausland, MD

    Peer

  • 

    

    Orly Vardeny, MD

    Peer

  • 

    

    Muthiah Vaduganathan, MD, MPH

    Peer

  1.25 credits 10 episodes

• 

  RestartResume

  MOA Deep Dive: The MRA Spectrum

  MinuteCE®

  MOA Deep Dive: The MRA Spectrum

  • 

    

    John McMurray, MD

    Peer

  • 

    

    Hiddo L. Heerspink, PhD

    Peer

  1.25 program credits

• 

  RestartResume

  Nonsteroidal MRAs: The CKD/T2D Advantage

  MinuteCE®

  Nonsteroidal MRAs: The CKD/T2D Advantage

  • 

    

    John McMurray, MD

    Peer

  • 

    

    Pardeep Jhund, MD, PhD

    Peer

  1.25 program credits

• 

  RestartResume

  Nonsteroidal MRAs: The CKD/T1D Potential

  MinuteCE®

  Nonsteroidal MRAs: The CKD/T1D Potential

  • 

    

    John McMurray, MD

    Peer

  • 

    

    Hiddo L. Heerspink, PhD

    Peer

  1.25 program credits

• 

  RestartResume

  Emerging Evidence in HF Care

  MinuteCE®

  Emerging Evidence in HF Care

  • 

    

    Pardeep Jhund, MD, PhD

    Peer

  • 

    

    John McMurray, MD

    Peer

  1.25 program credits
• advertisement

• 

  RestartResume

  Prolonged Anticoagulation After Primary PCI for STEMI Does Not Reduce Ischemic Events

  CME/CE

  Prolonged Anticoagulation After Primary PCI for STEMI Does Not Reduce Ischemic Events

• 

  RestartResume

  Safety and Efficacy of SGLT2i in Acute Heart Failure

  CME/CE

  Safety and Efficacy of SGLT2i in Acute Heart Failure

• 

  RestartResume

  Isolated Distal DVT in Cancer Cells for Longer DOAC Treatment

  PACE-CME

  Isolated Distal DVT in Cancer Cells for Longer DOAC Treatment